Literature DB >> 12669694

[International comparison of 19 clinical guideline programs--a survey of the AGREE Collaboration].

Jako Burgers1, Richard Grol, Niek Klazinga, Akke van der Bij, Marjukka Mäkelä, Joost Zaat.   

Abstract

Clinical practice guidelines are being developed in many countries throughout the world to improve quality of patient care. However, the methods used to develop guidelines vary among organisations. Therefore an international task group, the AGREE (Appraisal Guideline Research and Evaluation Europe) Collaboration, started in 1998 to work on the harmonisation and coordination of guideline development. Within this context a survey of national guideline programmes was conducted. Nineteen programmes from nine European countries, Australia, Canada, New Zealand and United States were described using a questionnaire. The items concerned the type of organisation, scope and purpose of the guidelines, people involved, methodology, products, implementation, evaluation, update procedure, and future plans. The results of this survey revealed a growing international consensus on the essential features of good guideline programmes. Most guideline programmes combine an evidence-based approach with informal and/or formal consensus procedures. No significant differences were found between governmental agencies and professional organisations. The budget for developing a single guideline varies from 10,000 to 200,000 EURO.

Entities:  

Mesh:

Year:  2003        PMID: 12669694

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  2 in total

1.  Evaluating Guidelines: A Review of Key Quality Criteria.

Authors:  Thomas Semlitsch; Wolfgang A Blank; Ina B Kopp; Ulrich Siering; Andrea Siebenhofer
Journal:  Dtsch Arztebl Int       Date:  2015-07-06       Impact factor: 5.594

Review 2.  Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.

Authors:  Yin Chen; Shilian Hu; Lei Wu; Xiang Fang; Weiping Xu; Gan Shen
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.